Concepedia

Pablo Santamarina‐Ojeda

PS

Statistics

Publications

14

Citations

440

H-Index

12

Active since

2018

Affiliations

Nanomaterials and Nanotechnology Research Center(Current)

Universidad de Oviedo

Instituto de Investigación Sanitaria del Principado de Asturias

Instituto de Salud Carlos III

Institució Catalana de Recerca i Estudis Avançats

Pablo Santamarina‐Ojeda is an author at Nanomaterials and Nanotechnology Research Center specializing in medicine, epigenetics, and epigenomics.

ORCID

Top concepts

Publications per year

2018–2024

14

Publications

14

Longitudinal genome-wide DNA methylation analysis uncovers persistent early-life DNA methylation changes

Raúl F. Pérez, Pablo Santamarina‐Ojeda, Juan Ramón Tejedor et al. · Journal of Translational Medicine · 2019 · 75 citations · Full text

Epigenetic downregulation of TET3 reduces genome‐wide 5hmC levels and promotes glioblastoma tumorigenesis

Antonella Carella, Juan Ramón Tejedor, María González García et al. · International Journal of Cancer · 2019 · 70 citations · Full text

, , +17

Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy

Obdulia Rabal, Edurne San José‐Eneriz, Xabier Agirre et al. · Journal of Medicinal Chemistry · 2018 · 60 citations · Full text

, , +20

Epigenetic dysregulation of<i>TET2</i>in human glioblastoma

María González García, Antonella Carella, Rocío G. Urdinguio et al. · Oncotarget · 2018 · 41 citations · Full text

Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma

Agustín F. Fernández, Gustavo F. Bayón, Marta Sierra et al. · Human Molecular Genetics · 2018 · 31 citations · Full text

, , +16

1–5 of 14